TrivarX Engages Beyond Drug Development to Progress Stabl-Im Safety Trial
· smallcaps.com.au
TrivarX engages Beyond Drug Development to push Stabl-Im Phase 1 safety trial, targeting H2 2026 start and data for regulatory progress.
TrivarX (ASX: TRI) has engaged specialist contract research organisation Beyond Drug Development to support the planned Phase 1 safety trial for its proprietary...